HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CA-104

structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Lactams: 2198
    - beta-Lactams: 2386
      - CA-104: 1
- Sulfur Compounds: 278
  - beta-Lactams: 2386
    - CA-104: 1
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - beta-Lactams: 2386
      - CA-104: 1

Experts

1.	Carr, Miriam: 1 article (02/2013)
2.	Greene, Lisa M: 1 article (02/2013)
3.	Hughes, Linda: 1 article (02/2013)
4.	McDonnell, Susan: 1 article (02/2013)
5.	Meegan, Mary J: 1 article (02/2013)
6.	Nathwani, Seema-Maria: 1 article (02/2013)
7.	O'Boyle, Niamh M: 1 article (02/2013)
8.	Zisterer, Daniela M: 1 article (02/2013)

Related Diseases

1.

02/01/2013 - "We established that two representative β-lactam compounds, CA-104 and CA-432, exerted both anti-endothelial effects [G2/M arrest and apoptosis of primary human umbilical vein endothelial cells (HUVECs)] and anti-angiogenic effects [inhibition of HUVEC migration and differentiation and reduced vascular endothelial growth factor (VEGF) release from MDA-MB-231 breast adenocarcinoma cells]. "

Related Drugs and Biologics

1.	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
2.	Lactams
3.	CA 432